Introduction to the TAVI Atlas
Aortic stenosis (AS) is the most frequent native valve disease in Europe and the United States and thus represents an important public health problem. The management of AS is made challenging by the fact that most patients are elderly with comorbidities which renders decision making and the choice of the most appropriate treatment more difficult.Alec Vahanian
Foreword of the TAVI Atlas
Developing TAVI has been a fascinating 20-year-long odyssey with a happy ending. Following in the footsteps of the transcatheter treatment of congenital pulmonic (1979) and congenital aortic (1983) valvular stenosis, and subsequently of mitral valvuloplasty (1984) and aortic valvuloplasty (1985) in adults, TAVI emerged in 2002 to profoundly alter the landscape of cardiovascular medicine. This new "disruptive" technology is among the most important medical breakthroughs to date. It evoked scepticism and criticism in the beginning but, thanks to innumerable clinical trials and evidence-based investigations, it is now widely accepted by the medical community, and this acceptance is continuing to grow.Alain Cribier
Editors, co-editors and editorial board
Meet the editors, co-editors and PCRonline editorial board of the TAVI Atlas.